A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab

Lawless, D, Pathak, S, Scambler, TE et al. (3 more authors) (2018) A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab. frontiers in Immunology, 9. ARTN 1527. ISSN 1664-3224

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Copyright © 2018 Lawless, Pathak, Scambler, Ouboussad, Anwar and Savic. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. (https://creativecommons.org/licenses/by/4.0/)
Keywords: TNFAIP3; A20; AOSD; tocilizumab; autoinflammatory
Dates:
  • Published: 4 July 2018
  • Accepted: 20 June 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Funding Information:
FunderGrant number
Swedish Orphan Biovitrum LtdNot Known
Depositing User: Symplectic Publications
Date Deposited: 20 Jul 2018 10:21
Last Modified: 20 Jul 2018 10:21
Status: Published
Publisher: Frontiers Media
Identification Number: https://doi.org/10.3389/fimmu.2018.01527
Related URLs:

Download

Share / Export

Statistics